Showing results (491-500 of 591) with videos related to

Sort By:
Pageof 60
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2011
Trypanosoma cruzi as an effective cancer antigen delivery vectorCaroline Junqueira, Luara I Santos, Bruno Galvão-Filho, et al.
Cancer Immunology, Immunotherapy : CII|March 4, 2008
Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patientKazuhide Tsuji, Toshitada Hamada, Akiko Uenaka, et al.
Cancer Immunity|December 19, 2003
Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancerPadmanee Sharma, Sacha Gnjatic, Achim A Jungbluth, et al.
Biochemical and Biophysical Research Communications|July 30, 1997
Characterization of posttranslational modifications of human A33 antigen, a novel palmitoylated surface glycoprotein of human gastrointestinal epitheliumG Ritter, L S Cohen, E C Nice, et al.
Cancer Immunity|August 2, 2003
NY-ESO-1 mRNA expression and immunogenicity in advanced prostate cancerTetsuya Nakada, Yuji Noguchi, Shuichiro Satoh, et al.
Cancer Science|October 13, 2006
A phase I radioimmunolocalization trial of humanized monoclonal antibody huA33 in patients with gastric carcinomaJunichi Sakamoto, Noboru Oriuchi, Erito Mochiki, et al.
Cancer Research|July 17, 2001
Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptorK Mishima, T G Johns, R B Luwor, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2006
Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patientsElke Jäger, Julia Karbach, Sacha Gnjatic, et al.
Molecular Cancer Therapeutics|August 27, 2003
Expression and targeting of human fibroblast activation protein in a human skin/severe combined immunodeficient mouse breast cancer xenograft modelKiki Tahtis, Fook-Thean Lee, Jennifer M Wheatley, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2007
Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancerKunle Odunsi, Feng Qian, Junko Matsuzaki, et al.
Pageof 60